Constantine S. Mitsiades
0000-0003-2321-8005
Publication & Citation Trends
Most Cited Works
Publications
644 total
Abstract 2980: Therapeutic potential of combined targeting of casein kinase 1 alpha (CK1 alpha) and CDK7/9 with the inhibitor BTX-A51 in human liposarcomas
Cited by 0
Semantic Scholar
Abstract 7058: NSD2 overexpression drives multiple myeloma dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome
Cited by 0
Semantic Scholar
P-182 Natural killer cells are active against myeloma cells with loss of tumor suppressor genes
Cited by 0
Semantic Scholar
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells OA
Cited by 26
Semantic Scholar
P881: CDK7 CONTRIBUTES TO METABOLIC REPROGRAMMING IN MM CELLS THROUGH C-MYC MEDIATED TRANSCRIPTIONAL CONTROL OF GLYCOLYTIC GENES OA
Cited by 0
Semantic Scholar
Systematic Functional Characterization for Loss of Function Events Cooperating with TP53 Loss in High-Risk 17p13(del) Multiple Myeloma OA
Cited by 0
Semantic Scholar
Abstract PR003: Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma
Cited by 0
Semantic Scholar
OAB-019: CRISPR screens with single-cell transcriptome readout reveal potential mechanisms of response to natural killer cell treatment in multiple myeloma
Cited by 1
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(319)
Protein Degradation and Inhibitors
(173)
Ubiquitin and proteasome pathways
(106)
Peptidase Inhibition and Analysis
(75)
Acute Myeloid Leukemia Research
(55)
Frequent Co-Authors
Affiliations
Broad Institute
Dartmouth College
Boston University
Queen's University Belfast
University of Maryland, Baltimore